Literature DB >> 18349291

Is mammography adequate for screening women with inherited BRCA mutations and low breast density?

Rachel Z Bigenwald1, Ellen Warner, Anoma Gunasekara, Kimberley A Hill, Petrina A Causer, Sandra J Messner, Andrea Eisen, Donald B Plewes, Steven A Narod, Liying Zhang, Martin J Yaffe.   

Abstract

BACKGROUND: Several observational studies have shown that magnetic resonance imaging (MRI) is significantly more sensitive than mammography for screening women over age 25 at high risk for hereditary breast cancer; however, MRI is more costly and less specific than mammography. We sought to determine the extent to which the low sensitivity of mammography is due to greater breast density.
METHODS: Breast density was evaluated for all patients on a high-risk screening study who were diagnosed with breast cancer between November 1997 and July 2006. Density was measured in two ways: qualitatively using the four categories characterized by the Breast Imaging Reporting and Data System and quantitatively using a computer-aided technique and classified as (a) <or=10%, (b) 11% to 25%, (c) 26% to 50%, and (d) >50% density. Comparison of sensitivity of mammography (and MRI) for each individual density category and after combining the highest two and lowest two density categories was done using Fisher's exact test.
RESULTS: A total of 46 breast cancers [15 ductal carcinoma in situ (DCIS) and 31 invasive] were diagnosed in 45 women (42 with BRCA mutations). Mean age was 48.3 (range, 32-68) years. Overall, sensitivity of mammography versus MRI was 20% versus 87% for DCIS and 26% versus 90% for invasive cancer. There was a trend towards greater mammographic sensitivity for invasive cancer in women with fattier breasts compared with those with greater breast density (37-43% versus 8-12%; P = 0.1), but this trend was not seen for DCIS.
CONCLUSION: It is necessary to add MRI to mammography for screening women with BRCA mutations even if their breast density is low.

Entities:  

Mesh:

Year:  2008        PMID: 18349291     DOI: 10.1158/1055-9965.EPI-07-0509

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  10 in total

Review 1.  Clinical and epidemiological issues in mammographic density.

Authors:  Valentina Assi; Jane Warwick; Jack Cuzick; Stephen W Duffy
Journal:  Nat Rev Clin Oncol       Date:  2011-12-06       Impact factor: 66.675

2.  Comparative effectiveness of screening and prevention strategies among BRCA1/2-affected mutation carriers.

Authors:  Victor R Grann; Priya R Patel; Judith S Jacobson; Ellen Warner; Daniel F Heitjan; Maxine Ashby-Thompson; Dawn L Hershman; Alfred I Neugut
Journal:  Breast Cancer Res Treat       Date:  2010-07-20       Impact factor: 4.872

3.  Should screening MRI be included in surveillance for patients treated with breast-conserving therapy?

Authors:  Murray Rebner; Inga Grills; Frank Vicini
Journal:  Nat Clin Pract Oncol       Date:  2008-11-25

Review 4.  Nuclear imaging of the breast: translating achievements in instrumentation into clinical use.

Authors:  Carrie B Hruska; Michael K O'Connor
Journal:  Med Phys       Date:  2013-05       Impact factor: 4.071

Review 5.  Redefining the sensitivity of screening mammography: A review.

Authors:  Alan B Hollingsworth
Journal:  Am J Surg       Date:  2019-02-02       Impact factor: 2.565

6.  Rapid increase in breast magnetic resonance imaging use: trends from 2000 to 2011.

Authors:  Natasha K Stout; Larissa Nekhlyudov; Lingling Li; Elisabeth S Malin; Dennis Ross-Degnan; Diana S M Buist; Marjorie A Rosenberg; Marina Alfisher; Suzanne W Fletcher
Journal:  JAMA Intern Med       Date:  2014-01       Impact factor: 21.873

Review 7.  Risk-reducing strategies for women carrying BRCA1/2 mutations with a focus on prophylactic surgery.

Authors:  Mohamed Salhab; Selina Bismohun; Kefah Mokbel
Journal:  BMC Womens Health       Date:  2010-10-20       Impact factor: 2.809

Review 8.  Screening BRCA1 and BRCA2 Mutation Carriers for Breast Cancer.

Authors:  Ellen Warner
Journal:  Cancers (Basel)       Date:  2018-11-30       Impact factor: 6.639

9.  Long-term results of screening with magnetic resonance imaging in women with BRCA mutations.

Authors:  K Passaperuma; E Warner; P A Causer; K A Hill; S Messner; J W Wong; R A Jong; F C Wright; M J Yaffe; E A Ramsay; S Balasingham; L Verity; A Eisen; B Curpen; R Shumak; D B Plewes; S A Narod
Journal:  Br J Cancer       Date:  2012-05-15       Impact factor: 7.640

10.  The Distinct Performances of Ultrasound, Mammograms, and MRI in Detecting Breast Cancer in Patients With Germline Pathogenic Variants in Cancer Predisposition Genes.

Authors:  Jiaqi Liu; Xin Wang; Lin Dong; Xin Huang; Hengqiang Zhao; Jiaxin Li; Shengkai Huang; Pei Yuan; Wenyan Wang; Jie Wang; Zeyu Xing; Ziqi Jia; Yue Ming; Xiao Li; Ling Qin; Gang Liu; Jiang Wu; Yiqun Li; Menglu Zhang; Kexin Feng; Jianming Ying; Xiang Wang
Journal:  Front Oncol       Date:  2021-07-13       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.